Now showing items 1-19 of 19

    • Baculovirus dual promoter expression vector 

      Summers, Max D.; Oker-Blom, Christian E. G. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1992-12-08)
      This invention relates to specifically designing and genetically engineering recombinant baculovirus for producing, in a compatible insect system, a desired protein, virus, protein hybrid, or virus hybrid. In particular ...
    • Compositions and methods for drug sensitization of parasites 

      Reddy, Manchi C. M.; Sacchettini, James C.; Zhou, Nian E.; McClutchen, Billy F. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2020-01-28)
      Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a an arylphenoxypropionate derivative, an aryloxyphenoxyacetate ...
    • Compositions and methods for drug sensitization of parasites 

      Sacchettini, James, C.; Miller, Matthew W.; Wallis, Deann; Zhou, Nian E.; Fossum, Theresa W. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2019-03-12)
      Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a rifamycin derivative or a pharmaceutically acceptable salt, ...
    • Compositions and methods of enhancing immune responses 

      Bottje, Walter; Hargis, Billy; Berghman, Luc; Kwon, Young Min; Cole, Kimberly; Cox, Mandy; Layton, Sherryll (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2013-12-10)
      Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
    • Compositions and methods of enhancing immune responses 

      Bottje, Walter; Hargis, Billy; Berghman, Luc; Kwon, Young Min; Cole, Kimberly; Cox, Mandy; Layton, Sherryll (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2018-06-26)
      Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
    • Compositions and methods of enhancing immune responses to Eimeria 

      Bottje, Walter; Hargis, Billy; Berghman, Luc; Kwon, Young Min; Cole, Kimberly; Cox, Mandy; Layton, Sherryll; El-Ashram, Saeed; Barta, John; Tellez, Guillermo (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2018-07-10)
      Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods ...
    • Compositions and methods of enhancing immune responses to Eimeria 

      Bottje, Walter; Hargis, Billy; Berghman, Luc; Kwon, Young Min; Cole, Kimberly; Cox, Mandy; Layton, Sherryll; El-ashram, Said; Barta, John; Tellez, Guillermo (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2015-02-17)
      Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods ...
    • Compositions and methods of enhancing immune responses to Eimeria 

      Bottje, Walter; Hargis, Billy; Berghman, Luc; Kwon, Young Min; Cole, Kimberly; Cox, Mandy; Layton, Sherryll; El-Ashram, Saeed; Barta, John; Tellez, Guillermo (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 11/24/2020)
      Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods ...
    • Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection 

      Barta, John R.; Berghman, Luc; Shivaramaiah, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2018-02-06)
      Vaccine, vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection 

      Barta, John R.; Berghman, Luc; Shivaramaian, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy, (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2019-06-25)
      Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • DbpA compositions 

      Guo, Betty P.; Hook, Magnus (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2001-04-10)
      Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
    • DbpA compositions and methods of use 

      Guo, Betty P.; Hook, Magnus (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2001-11-06)
      Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
    • Decorin binding protein compositions 

      Guo, Betty; Hook, Magnus (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2001-05-08)
      Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
    • Decorin binding protein compositions and methods of use 

      Guo, Betty; Hook, Magnus (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1998-12-29)
      Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
    • Decorin binding protein compositions and methods of use 

      Guo, Betty P.; Hook, Magnus (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2001-06-19)
      Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
    • Decorin binding protein essential peptides and methods of use 

      Hook, Magnus A.; Brown, Eric L. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2003-02-11)
      Borrelia burgdorferi, the causative agent of Lyme disease, expresses on its surface a decorin binding protein, DbpA and DbpB. Lysine residues necessary for DbpA binding to decorin and DbpA peptides containing these critical ...
    • Method of treating birds 

      Kogut, Michael H.; DeLoach, John R.; Hargis, Billy M.; McGruder, Edward D. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1997-12-16)
      A method of combatting microbial infections, including Escherichia coli and Salmonella infections, in immature birds by in ovo administration of an immune lymphokine (ILK) containing preparation in an amount effective to ...
    • Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features 

      Hillman, Jeffrey D.; Smith, James Leif; Wilson-Stanford, Shawanda R. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2018-05-08)
      The invention provides improvements of lantibiotics useful for reducing the numbers of microbes or the reproduction of microbes in or on subjects or objects. One embodiment of the invention provides variants of antibiotics ...
    • Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same 

      Faulkner, Olivia B.; Bielke, Lisa; Calhoun, Leona Nicole; Berghman, Luc; Hargis, Billy (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 6/16/2020)
      Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...